Tacrolimus’s Time Below Therapeutic Range Is Associated With Acute Pancreatic Graft Rejection and the Development of De Novo Donor-specific Antibodies

Tacrolimus is pivotal in pancreas transplants but poses challenges in maintaining optimal levels due to recipient differences. This study aimed to explore the utility of time spent below the therapeutic range and intrapatient variability in predicting rejection and de novo donor-specific antibody (d...

Full description

Bibliographic Details
Main Authors: Diana Rodríguez-Espinosa, José Jesús Broseta, Enrique Montagud-Marrahí, Carolt Arana, Joana Ferrer, Miriam Cuatrecasas, Ángeles Garcia-Criado, Antonio J. Amor, Fritz Diekmann, Pedro Ventura-Aguiar
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Transplant International
Subjects:
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2024.12591/full